CompanyProfileSukuk

Actions

Middle East Healthcare Company (Saudi German Health) Sukuk

5019
SAUDI GERMAN HEALTH SUKUK 03/2029
100.000
-
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Sukuk/Bonds Index
Historical

Stats Overview

  • Prev. Close 100.000
  • Open -
  • High -
  • Low -
  • Nominal Value Traded (^) -
  • Value Traded (^) -
  • No. Of Trades -
  • Avg. Trade Size -

Last Trade

  • Date/Time 13-09-2026
    16:08:02
  • Yield 7.1994
  • Price 100.000
  • Nominal Value Traded (^) 11,000

Best Bid

  • Yield -
  • Price -
  • Volume -

Best Offer

  • Yield 7.1993
  • Price 100.000
  • Volume 302,000
100.000 %
-

Coupon Payments

Coupon Period

From To Number Of Days To Coupon Coupon Rate Payment Per Sukuk/Bond (^)
2026-09-06 2026-12-06 90 7.20000 18.0000
  • Average Trade Size = Cumulative / # Of Trades
  • Mo: Market Order

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

CompanyProfileSukukv2Announcement

Actions
Jump To:
  • Announcements
  • Financials
  • Issuance Profile
  • Issuer Profile

Announcements

Announcements
  • A
    4009 SAUDI GERMAN HEALTH
     -0.7%

    Middle East Healthcare Company (Saudi German Health) Announces the Appointment of the Chairman of the Audit Committee

    1448/04/02     13/09/2026 16:14:39
  • A
    4009 SAUDI GERMAN HEALTH
     -0.7%

    Middle East Healthcare Company (Saudi German Health) Announces the Appointment of a Board Member to Fill the Vacant Seat on its Board of Directors

    1448/04/02     13/09/2026 16:14:24
  • A
    4009 SAUDI GERMAN HEALTH
     -0.7%

    Middle East Healthcare Company (Saudi German Health) Announces the Resignation of a Board Member and Chairman of the Audit Committee

    1448/03/25     07/09/2026 09:06:10
  • A
    4009 SAUDI GERMAN HEALTH
     -0.7%

    Middle East Healthcare Company (Saudi German Health) Announces Its Interim Consolidated Financial Results for the Period Ending on 30 June 2026 (Six Months)

    1448/02/28     11/08/2026 16:27:56
  • A
    4009 SAUDI GERMAN HEALTH
     -0.7%

    Middle East Healthcare Company (Saudi German Health) Announces the Appointment of an Audit Committee Member

    1448/02/15     29/07/2026 16:27:40
View All Announcements

CompanyProfileSukukv2Financials

Actions
Jump To:
  • Announcements
  • Financials
  • Issuance Profile
  • Issuer Profile

Financials

  • FINANCIAL INFORMATION
  • FINANCIAL STATEMENTS AND REPORTS
  • Annually
  • Quarterly
Balance Sheet 2025-12-31 2024-12-31 2023-12-31
Total Assets
5,466,239
5,125,314
5,173,150
-
Total Liabilities
3,538,538
3,451,253
3,608,388
-
Total Shareholders Equity (After Deducting the Minority Equity)
1,872,363
1,626,109
1,519,080
-
Total Liabilities and Shareholders Equity
5,466,239
5,125,314
5,173,150
-
Statement of Income 2025-12-31 2024-12-31 2023-12-31
Total Revenue (Sales/Operating)
3,102,633
2,882,818
2,653,170
-
Net Profit (Loss) before Zakat and Tax
317,912
308,279
198,159
-
Zakat and Income Tax
-16,028
-26,277
-17,983
-
Net Profit (Loss) Attributable to Shareholders of the Issuer
301,884
282,002
180,176
-
Total Comprehensive Income Attributable to Shareholders of the Issuer
292,274
306,499
154,119
-
Profit (Loss) per Share
3.28
3.06
1.96
-
Cash Flows 2025-12-31 2024-12-31 2023-12-31
Net Cash From Operating Activities
544,603
939,264
191,083
-
Net Cash From Investing Activities
-338,371
-507,294
-241,989
-
Net Cash From Financing Activities
-232,212
-424,110
79,726
-
Cash and Cash Equivalents, Beginning of the Period
52,282
44,423
15,602
-
Cash and Cash Equivalents, End of the Period
26,301
52,283
44,423
-
All Figures are in Thousands Thousands Thousands
All Currency In ^ ^ ^
Last Update Date 2026-02-24 2025-03-03 2024-04-03
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
Balance Sheet 2026-06-30 2026-03-31 2025-09-30 2025-06-30
Total Assets
5,164,019
5,467,522
5,275,388
5,317,993
Total Liabilities
3,564,409
3,514,644
3,376,240
3,461,226
Total Shareholders Equity (After Deducting the Minority Equity)
1,542,848
1,898,165
1,843,146
1,803,592
Total Liabilities and Shareholders Equity
5,164,019
5,467,522
5,275,388
5,317,993
Statement of Income 2026-06-30 2026-03-31 2025-09-30 2025-06-30
Total Revenue (Sales/Operating)
845,520
765,234
768,972
791,130
Net Profit (Loss) before Zakat and Tax
39,735
30,615
49,045
68,993
Zakat and Income Tax
-5,387
-4,920
-8,755
-5,328
Net Profit (Loss) Attributable to Shareholders of the Issuer
34,348
25,696
40,291
63,665
Total Comprehensive Income Attributable to Shareholders of the Issuer
34,502
25,802
39,554
63,407
Profit (Loss) per Share
0.37
0.28
0.69
0.69
Cash Flows 2026-06-30 2026-03-31 2025-09-30 2025-06-30
Net Cash From Operating Activities
355,933
281,788
537,254
185,807
Net Cash From Investing Activities
-135,741
-153,273
-230,186
-43,067
Net Cash From Financing Activities
-163,952
-130,719
-289,375
-163,100
Cash and Cash Equivalents, Beginning of the Period
26,301
26,301
52,282
52,282
Cash and Cash Equivalents, End of the Period
82,542
24,097
69,975
31,922
All Figures are in Thousands Thousands Thousands Thousands
All Currency In ^ ^ ^ ^
Last Update Date 2026-08-20 2026-05-04 2025-11-03 2025-08-04
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
Display Previous Periods

CompanyProfileSukukv2Fund

Actions
Jump To :
  • Announcements
  • Financials
  • Issuance Profile
  • Issuer Profile

Issuance Profile


Issuance Information
Issuer Middle East Healthcare Co.
Listing Date 2024-03-13
Lead Manager Alrajhi Capital Company
Issuance Credit Rating N/A
Issuer Credit Rating Not rated
Debt Instrument Status Senior, Unsecured
Debt Instrument Type and Structure Mudaraba, Murabaha
Accumulative Issuance Amount (^) 1,000,000,000
Issue Date 2024-03-06
Maturity and Early Redemption Date 2029-03-06
Coupon Rate % 7.2
Coupon Distribution Frequency Quarterly
Zakat treatment -
Trading Method Electronic
Collateral None
Minimum Subscription Amount Per Investor -
Par Value 1,000
Identification Code SA16100IEDJ2
Additional Information
Registrar Securities Depository Center Company (Edaa)
Payment Administrator Alrajhi Capital Company
Debt Instrument Agent Alrajhi Capital Company
Jump To :
  • Announcements
  • Financials
  • Issuance Profile
  • Issuer Profile

Issuer Overview

Construct, manage, operate and maintenance for hospitals, clinics, centers, institutes, rehabilitation centers, physiotherapy, laboratory, X-Ray, pharmacies, purchasing of lands to construct buildings and investment for the company in medical projects.

Issuer History

Middle East Healthcare Company (MEAHCO) is a closed joint stock company incorporated pursuant to the Ministerial Resolution number 2554 dated 16/03/1425H (corresponding to 05/05/2004G) and registered under commercial registration number 4030149460 dated 06/04/1425H (corresponding to 25/05/2004G) with a paid-up share capital of (SAR 590000000) five hundred and ninety million Saudi Riyals, of which (SAR 42040000) forty-two million and forty thousand Saudi Riyals were paid through cash contributions, while the remaining (SAR 547960000) five hundred and forty seven million and nine hundred and sixty thousand Saudi Riyals were paid through in kind contributions made by BAB consisting of SGH Madinah (including its land and buildings) SGH Aseer (including its land and buildings) and shares representing 80% of the share capital of BABAS (former owner and operator of SGH Riyadh) On 02/02/1435H (corresponding to 5/12/2013G) the EGA of the Company agreed to increase the Companies share capital from (SAR 590000000) five hundred ninety million Saudi Riyals to (SAR 767000000) seven hundred sixty seven million Saudi Riyals The increase of (SAR 177000000) one hundred and seventy seven million Saudi Riyals was covered through capitalization of the Shareholders account that resulted from their offering of additional in kind contributions to the Company which consisted of the following 1 SGH Jeddah 2 98% of the shares of AJ Sons 3 39.96% of NHCs share capital 4 Management Supervision Agreements for hospitals owned by third parties outside the Kingdom located in Dubai (UAE) Cairo (Egypt) and Sanaa (Yemen) 5 20% of BABAS which resulted in the Company fully owning BABAS and therefore fully owning SGH Riyadh which was later converted into a fully owned branch by the Company under commercial registration number 1010162269 dated 24/07/1421H (corresponding to 21/10/2000G) and a plot of land in the city of Dammam with a surface area of (30,000) thirty thousand m2 (Dammam Land) On 28/7/1436H (corresponding to 17/5/2015G) the EGA agreed to further increase the Companies share capital from (SAR 767000000) seven hundred and sixty-seven million Saudi Riyals to (SAR 920400000) nine hundred and twenty million four hundred thousand Saudi Riyals The increase of (SAR 153400000) one-hundred and fifty-three million four hundred thousand Saudi Riyals was covered through capitalization of the retained earnings account.

Equity Profile
Authorized Capital (^) 920,400,000 Issued Shares 92,040,000 Paid Capital (^) 920,400,000
Per Value/Share 10 Paid up Value/Share 10 Last Update 2026/07/09
  • Basic Information
  • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
  • Date Established

    2004/05/05

  • Financial Year End

    31//12

  • Listing Date

    2016-03-29

  • External Auditors

    BDO Dr. Mohamed Al-Amri & Co.

  • Number Of Employees

    4322

  • Chairman

  • Abdulaziz Hasheem Ashwee Alanazi
    Independent

    Abdulaziz Hasheem Ashwee Alanazi
    • BD Session Start
      2026-07-08
      Designation
      Chairman
    • BD Session End
      2030-07-07
      Classification
      Independent
  • Senior Executives

  • Nezar Mohammed Sultan Bahabri
    CEO

    Nezar Mohammed Sultan Bahabri
    • BD Session Start
      2026-01-01
      Designation
      Senior Executives
    • BD Session End
      -
      Classification
      CEO

    Sultan Adel Kamil Sindi
    CFO

    Sultan Adel Kamil Sindi
    • BD Session Start
      2026-02-08
      Designation
      Senior Executives
    • BD Session End
      -
      Classification
      CFO
  • Board of Directors

  • Dr. Ahmad Abdullah Ahmad Alali
    Deputy Chairman - Independent

    Dr. Ahmad Abdullah Ahmad Alali
    • BD Session Start
      2026-07-08
      Designation
      Board of Directors
    • BD Session End
      2030-07-07
      Classification
      Deputy Chairman - Independent

    Bo Nicklas Garemo
    Independent

    Bo Nicklas Garemo
    • BD Session Start
      2026-07-08
      Designation
      Board of Directors
    • BD Session End
      2030-07-07
      Classification
      Independent

    Dr. Osama Sadik Abdurrahman Tayeb
    Independent

    Dr. Osama Sadik Abdurrahman Tayeb
    • BD Session Start
      2026-07-08
      Designation
      Board of Directors
    • BD Session End
      2030-07-07
      Classification
      Independent

    Dr. Fareed Ahmed Mohamed Khouqeer
    Independent

    Dr. Fareed Ahmed Mohamed Khouqeer
    • BD Session Start
      2026-07-08
      Designation
      Board of Directors
    • BD Session End
      2030-07-07
      Classification
      Independent

    Dr. Abdulkarim Hamad Alnujaidi
    Independent

Dr. Abdulkarim Hamad Alnujaidi
  • BD Session Start
    2026-07-08
    Designation
    Board of Directors
  • BD Session End
    2030-07-07
    Classification
    Independent

Investor Relations

Contact Name

MUATH MOHAMMED ALZARKAN

Address :

Jeddah, Batterjee Street, Al Zahra District P.O.BOX2550 Jeddah 21461

Contact Details :

Telephone : 0966-12-2606000
FAX : 00966-12-6835874
Email : President4@sghgroup.net

Website :

saudigermanhealth.com

Add To Watchlist
In your Watchlist
Add To Watchlist

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.